Adicet Bio Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies ...

The characterization of product-related variants in monoclonal antibodies involves identifying and quantifying the size and charge of variants that can impact.. In biotherapeutics manufacturing, ...

Overcoming distribution hurdles to meet demand, cold chain solutions and strategies, and streamlining the supply chain to mitigate rising costs. Unique capabilities needed to overcome obstacles for ...

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...

Dr. Marc Damelin possesses extensive industry experience in oncology drug discovery and development across a variety of mechanisms of action. Adds Nimble's lead asset and a pipeline of other novel ...

Prasinezumab continues to be well tolerated and no new safety signals were observed.

Evidence of efficacy and safety data support the potential for vatiquinone to fill the significant unmet need for patients ...

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

Partnership leverages PHICS technology to bring together a kinase and target of interest to modulate protein function.

A Phase 2 study showed encouraging results with Trodelvy as a second-line treatment for extensive-stage small cell lung ...

Novo Nordisk will soon acquire from Novo Holdings Catalent’s three fill-finish sites located in Italy, the U.S., and Belgium.